Accenture Makes Strategic Investment in African Fintech Startup Okra
22 Apr, 2021
Seattle biotech startup Outpace Bio raises $30M to fight cancer with custom-designed proteins
– Outpace Bio raised $30m in Series A funding.
– The round was led by ARTIS Ventures and Lyell Immunopharma, and joined by Abstract Ventures, Civilization Ventures, Mubadala Capital (the asset management arm of Mubadala Investment Company), Playground Global, Sahsen Ventures, and WRF Capital.
– Total funding to date is $30m.
